Epithelioid sarcoma as the prototype for personalized therapy in soft tissue sarcoma

Per Med. 2020 Jul 1;17(4):241-244. doi: 10.2217/pme-2020-0006. Epub 2020 Jun 26.

Authors

Tarek Assi^{1

2}, Elie Rassy¹, Hussein Nassereddine¹, Fadi Farhat², Joseph Kattan¹

Affiliations

¹ Saint-Joseph University, Faculty of medicine, Beirut, Lebanon.
² Oncology Department, Hammoud Hospital, Saida, Lebanon.

PMID: 32589100
DOI: 10.2217/pme-2020-0006

No abstract available

Keywords: chemotherapy; epithelioid sarcoma; personalized therapy; soft tissue sarcomas; targeted therapy; tazemetostat.

Publication types

Editorial

MeSH terms

Humans
Precision Medicine / methods*
Sarcoma / therapy*
Soft Tissue Neoplasms / therapy